Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,102 | -18,546 | -7,894 | N/A | N/A |
| Depreciation Amortization | 1,545 | 1,557 | 1,592 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,186 | 731 | -768 | N/A | N/A |
| Other Working Capital | 2,263 | -1,537 | 7,745 | N/A | N/A |
| Other Operating Activity | 7,265 | 9,101 | 3,398 | 0 | 0 |
| Operating Cash Flow | $-39,843 | $-8,694 | $4,073 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,313 | -654 | -250 | N/A | N/A |
| Purchase Of Investment | -119,291 | -30,646 | N/A | N/A | N/A |
| Sale Of Investment | 65,698 | 102 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -2,443 | 0 | 0 | 0 |
| Investing Cash Flow | $-58,906 | $-33,641 | $-250 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 322 | N/A | N/A | N/A |
| Debt Issued | 6,175 | 53,183 | 249 | N/A | N/A |
| Debt Repayment | N/A | -1,285 | -731 | N/A | N/A |
| Common Stock Issued | 77 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 96,953 | -55 | 0 | 0 | 0 |
| Financing Cash Flow | $103,205 | $52,165 | $-482 | $N/A | $N/A |
| Exchange Rate Effect | -485 | 142 | -41 | N/A | N/A |
| Beginning Cash Position | 13,898 | 3,926 | 626 | N/A | N/A |
| End Cash Position | 17,869 | 13,898 | 3,926 | N/A | N/A |
| Net Cash Flow | $3,971 | $9,972 | $3,300 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,843 | -8,694 | 4,073 | N/A | N/A |
| Capital Expenditure | -5,314 | -654 | -264 | N/A | N/A |
| Free Cash Flow | -45,157 | -9,348 | 3,809 | 0 | 0 |